Central changes in nociceptin dynorphin B and Met-enkephalin-Arg-Phe in different models of nociception

Brain Research

Volumn 857, Issue 1-2, 2000, Pages 212-218

  Rosén, Annika ^a,b   Lundeberg, Thomas ^a   Bytner, Beata ^a   Nylander, Ingrid ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Department of Odontology   (Sweden)

^c Division of Pharmacology   (Sweden)

Author keywords

Descending pathway; Dynorphin B; Enkephalin; Inflammation; Nerve lesion; Nociceptin; Nociception; Periaqueductal gray

Indexed keywords

CARRAGEENAN; DYNORPHIN B; METENKEPHALIN[6 ARGININE 7 PHENYLALANINE]; NOCICEPTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; HYPOTHALAMUS; IMMUNOREACTIVITY; MALE; NERVE INJURY; NEUROGENIC INFLAMMATION; NOCICEPTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SCIATIC NERVE; SPINAL CORD;

ANIMALS; BRAIN; DYNORPHINS; EFFERENT PATHWAYS; ENDORPHINS; ENKEPHALIN, METHIONINE; INFLAMMATION; MALE; NERVE CRUSH; NOCICEPTORS; OPIOID PEPTIDES; PAIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033952133     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02432-4     Document Type: Article

References (48)

1. Andoh T., Itoh M., Kuraishi Y. Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation. NeuroReport. 8:1997;2793-2796.
2. Bennett G.J., Xie Y.-K. A peripheral mononeuropathy in the rat produces disorders of pain sensation like those in man. Pain. 33:1988;87-107.
3. Beyer A., Schäfer M., Stein C. Antinociceptive effects of dynorphin peptides in a model of inflammatory pain. Pain. 70:1997;141-147.
4. Brodin K., Rosén A., Iwarsson K., Ögren S.-O., Brodin E. Increased levels of substance P and cholecystokinin in rat cerebral cortex following repeated electroconvulsive shock and subchronic treatment with a serotonin uptake inhibitor. Acta Physiol. Scand. 136:1989;613-614.
5. Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., Grandy D.K. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor type. FEBS Lett. 347:1994;284-288.
6. Darland T., Heinricher M.M., Grandy D.K. Orphanin FQ/nociceptin: a role in pain analgesia, but so much more. TINS. 21(5):1998;215-221.
7. de Ceballos M.L., Jenner P., Marsden C.D. Increased Met-enkephalin and decreased substance P in spinal cord following thermal injury to one limb. Neuroscience. 36(3):1990;731-736.
8. Draisci G., Kajander K.C., Dubner R., Bennett G.J., Iadarola M.J. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res. 560:1991;186-192.
9. Fallon J.H., Leslie F.M. Distribution of dynorphin and enkephalin peptides in the rat brain. J. Comp. Neurol. 249(3):1986;293-336.
10. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., Houtani T., Sugimoto T. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 343:1994;42-46.
11. Gorio A., Vergani l., Ferro L., Prino G., Di Giulio A.M. Glycosaminoglycans in nerve injury: II. Effects on transganglionic degeneration and on the expression of neurotropic factors. J. Neurosci. Res. 46(5):1996;572-580.
12. Grisel J.E., Mogil J.S., Belknap J.K., Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, antiopiate peptide. NeuroReport. 7:1996;2125-2129.
13. Hao J.-X., Xu I.S., Wiesenfeld-Hallin Z., Xu X.-J. Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation. Pain. 76:1998;385-393.
14. Hassan A.H., Pzewlocki R., Herz A., Stein C. Dynorphin, a preferential ligand for kappa-opioid receptors is present in nerve fibers and immune cells within inflamed tissue of rat. Neurosci. Lett. 140(1):1992;85-88.
15. Houtani T., Nishi M., Takeshima H., Nukada T., Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem. Biophys. Res. Commun. 219:1996;714-719.
16. Iadarola M.J., Brady L.S., Draisci G., Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain. 35:1988;313-326.
17. Jones R.S.G., Olpe S.-O. An increase in sensitivity of rat cingulate cortical neurons to substance P occurs following withdrawal of chronic administration of antidepressant drugs. Br. J. Pharmacol. 81:1984;659-664.
18. King M.A., Rossi G.C., Chang A.H., Williams L.S., Pasternak G.W. Spinal analgesic activity of orphanin FQ/nociceptin and its fragment. Neurosci. Lett. 223:1997;113-116.
19. Klein C.M., Sorkin L.S., Chung K., Coggeshall R.E. Unmyelinated primary afferent fiber stimulation depletes dynorphin A (1-8) immunoreactivity in rat ventral horn. Brain Res. 566(1-2):1991;70-76.
20. Lundeberg T., Alstergren P., Appelgren A., Appelgren B., Carleson J., Kopp S., Theodorsson E. A model for experimentally induced temporomandibular joint arthritis in rats: effects of carrageenan on neuropeptide-like immunoreactivity. Neuropeptides. 30(1):1996;37-41.
21. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptors mRNA expression in the rat CNS: anatomical and functional implications. TINS. 18(1):1995;22-29.
22. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alviberie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costenin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
23. Mollereau C., Parmentier M., Mailleux P., Butour J.-L., Moisand C., Chalon P., Caput D., Vassart G., Meunier J.-C. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 241:1994;33-38.
24. Morgan M.M., Grisel J.E., Robbins C.S., Grandy D.K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. NeuroReport. 8(16):1997;3431-3434.
25. Nakasawa T., Ikeda M., Kaneko T., Yamatsu K., Kitagawa K., Kiso Y. Bestatin potentiates the antinociception but not the motor dysfunction induced by intracerebrally administered dynorphin B in mice. Neuropeptides. 13(4):1989;277-283.
26. Nothacker H.-P., Reinscheid R.K., Mansour A., Henningsen R.A., Ardati A., Monsma F., Watson S.J., Civelli O. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. 93:1996;8677-8682.
27. Nylander I., Vlaskovska M., Terenius L. Brain dynorphin and enkephalin systems in Fisher and Lewis rats: effects of morphine tolerance and withdrawal. Brain Res. 683:1995;25-35.
28. Nylander I., Stenfors C., Tan-No K., Mathé A.A., Terenius L. A comparison between microwave irradiation and decapitation: basal levels of dynorphin and enkephalin and the effect of chronic morphine treatment on dynorphin peptides. Neuropeptides. 31:1997;357-365.
29. Pan Y.-X., Xu J., Pasternak G.W. Cloning and expression of a cDNA encoding a mouse brain orphanin FQ/nociceptin precursor. Biochem. J. 315:1996;11-13.
30. Parris W.C., Janicki P.K., Johnson B.W., Mathews L. Infrared laser diode irradiation has no behavioral or biochemical effect on pain in the sciatic nerve ligation-induced mononeuropathy in rat. Anesth. Prog. 41(4):1994;95-99.
31. Przewlovki R., Hassan A.H.S., Lason W., Epplen C., Herz A., Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience. 48:1992;491-500.
32. Reinscheid R.K., Nothhacker H.-P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
33. Reisine T. Review: neurotransmitter receptors: V. Opiate receptors. Neuropharmacology. 34:1995;463-472.
34. Riedl M., Shuster S., Vilchanova L., Wang J., Loh H.H., Elde R. Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. NeuroReport. 7:1996;1369-1372.
35. A. Rosén, T. Andacheh, I. Nylander, T. Lundeberg, The tissue levels of dynorphin B increased in the ventral part of the periaqueductal grey and in the hypothalamus in peripheral nerve lesioned rats, 33:e International Congress of Physiological Science, St. Petersburg, Russia, 1997.
36. Rossi G.C., Leventhal L., Pasternak G.W. Naloxone sensitive orphanin FQ-induced analgesia in mice. Eur. J. Pharmacol. 311:1996;R7-R8.
37. Schulz S., Schreff M., Nüss D., Gramsch C., Höllt V. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions. NeuroReport. 7:1997;3021-3025.
38. C. Sommer, R.R. Myers, Neurotransmitters in the rostral ventral medulla and periaqueductal gray in experimental painful neuropathy, in: T.S. Jensen, J.A. Turner, Z. Wiesenfelt-Hallin (Eds.), Proceedings of the 8th World Congress on Pain, Progress in Pain Research and Management, Vol. 8. IASP Press, Seattle, 1996, pp. 601-612.
39. Stanfa L., Dickenson A. Spinal opioid systems in inflammation. Inflammation Res. 44:1995;231-241.
40. Tan-Nok K., Taira A., Sakurada T., Inoue M., Sakurada S., Tadano T., Sato T., Sakurada C., Nylander I., Silberring J., Terenius L., Kisara K. Inhibition of dynorphin-converting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test. Eur. J. Pharmacol. 314(1-2):1996;61-67.
41. Tian J.-H., Xu W., Fang Y., Mogil J.S., Grisel J.E., Grandy D.K., Han J.-S. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br. J. Pharmacol. 129:1997;676-680.
42. Tian J.-H., Xu W., Zhang W., Fang Y., Grisel J.E., Mogil J.S., Grandy D.K., Han J.-S. Involvement of endogenous orphanin FQ in electroacupuncture-induced analgesia. NeuroReport. 8:1997;497-500.
43. Wagner R., De Leo J.A., Coombs D.W., Willenbring S., Fromm C. Spinal dynorphin immunoreactivity increases bilaterally in a neuropathic pain model. Brain Res. 629(2):1993;323-326.
44. Wilson J.L., Nayanar V., Walker J.S. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration. Br. J. Pharmacol. 188(7):1996;1754-1760.
45. Williams F.G., Mullet M.A., Beitz A.J. Basal release of Met-enkephalin and neurotensin in the ventrolateral periaqueductal gray matter of the rat: a microdialysis study of antinociceptive circuits. Brain Res. 690(2):1995;207-216.
46. Vogt B., Wiley R., Jensen E. Localization of mu and delta receptors to anterior cingulate afferents and projection neuron and input/output model of mu regulation. Exp. Neurol. 135:1995;83-92.
47. 1) receptor agonist, on the thermal hyperalgesia induced by carrageenan injection into the rat paw. Brain Res. 754:1997;329-332.
48. Xu X.-J., Hao J.-X., Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. NeuroReport. 7:1996;2092-2094.